Navigation Links
Remuda Ranch Programs for Eating and Anxiety Disorders Reports Need for Increasing Awareness of Eating Disorders in Males
Date:7/2/2009

PHOENIX, July 2 /PRNewswire/ -- As many as five to ten million males in the U.S. struggle quietly with an eating disorder because they're ashamed to admit they have the illness, reports Remuda Ranch Programs for Eating and Anxiety Disorders. Healthcare professionals, family members and close friends often are unaware of the high-risk behaviors in males that may signify an eating disorder. Therefore, effective intervention is often not available to the male population.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090604/CG27861LOGO

"It is a reality that boys and men do have eating disorders and ignoring the problem may only allow it to get to a life threatening state," said Sam Lample, therapist and assistant clinical director of ReddStone, A Remuda Program for Boys. "Early and proper diagnosis from healthcare providers could be a powerful force in preventing male eating disorders from becoming as common as they have become in females."

ReddStone is an inpatient program that treats boys 17 and under who are struggling with anorexia, bulimia and binge-eating disorder. It follows the Remuda Model of Treatment that is based on a bio-psycho-social-spiritual framework. The program doesn't just treat the disorder; it treats the entire patient and offers them the best possible chance for complete and lasting recovery from eating disorders.

Research suggests that at least 1 in 4 pre-teen cases of anorexia are male. There are thousands of males with eating disorders in our society. Historically, it was thought that the ratio of boys to girls with eating disorders was 1:10, but more recent research indicates that it may be closer to 1:3.

"Over t
'/>"/>

SOURCE Remuda Ranch Programs for Eating and Anxiety Disorders
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
2. Tryton Medical Receives CE Mark Approval for its Side-Branch Stent
3. Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing
4. Environmental Operating Solutions Completes Initial Tranche of $2.5 Million Institutional Financing
5. Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise
6. Amarin Announces Completion of the First Tranche of $60 Million Private Placement
7. Tree branching key to efficient flow in nature and novel materials
8. Stunning Attendance for ChemOutsourcing Show on September 8-9 in Long Branch, NJ
9. Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute
10. Arete Therapeutics Closes $16.7 Million in Final Tranche of Its Series A Financing
11. Intradigm Closes Final Tranche of $21.4 Million Series B Financing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...ire/ -- The endangered black-footed ferrets inhabi... carnivore feeds on prairie dogs. The prairie do... population die-offs in towns occur. The U.S. Fis...erret breeding program and has been releasing trai...bitat. Unfortunately, plague can sweep through an...
(Date:11/5/2009)...Newswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq...ts for processing and storing adult stem cells, to...al 2010. ,, For the quarter ended September 30,...on, a 15 percent increase over revenues of $4.5 mi... said the key contributors to the growth in revenu...
(Date:11/5/2009)...-FirstCall/ -- BioSpecifics Technologies Corp. (Na...ing first-in-class collagenase-based products, tod...uarter ended September 30, 2009. ,, "We were e...e FDA,s Arthritis Advisory Committee unanimously r...FLEX(TM) for the treatment of Dupuytren,s disease,...
(Date:11/5/2009)...RNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SN... receptor-based technologies to discover novel fla...ient supply industries, today provided a corporate...rd quarter ended September 30, 2009. Revenues wer...ared to $4.0 million for the third quarter of 2008...
Breaking Biology Technology:Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14
... GeneGo, Inc., the leading systems biology tools ...h of the University of Glasgow will join the Met...the program is to develop a series of blueprint pa...s, Hematopoietic, Mesenchymal, Multipotent, Neopla..."We feel that it is important to support such an i...
...2S Inc., a global provider of image management ser...nical trials, announced today that the company wil...e-of-the-art image management can enhance DXA (Dua...ervices for bone mineral density trials and issues...urements with DXA. , (PRW...
... Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC) a...onal,Staff Determination letter (the "Determinatio...the "Staff") of The NASDAQ Stock Market indicating...Rule 4350(i)(1)(C) when the,Company amended the ac...SMI"),and issued additional common shares to SMI s...
Other Biology Technology:University of Glasgow Becomes a Member of GeneGo's MetaMiner Stem Cell Partnership Program 2Free DXA Bone Mineral Density and Body Composition in Clinical Trials Webinars to be Held by M2S DXA Division Expert 2Cell Therapeutics Receives Additional NASDAQ Notification 2Cell Therapeutics Receives Additional NASDAQ Notification 3Cell Therapeutics Receives Additional NASDAQ Notification 4
(Date:11/4/2009)...SON, N.J., Oct. 20 Quest...,s leading provider of diagnostic testing, informa...arter ended September 30, 2009, income from contin... diluted share, from $160 million, or $0.81 per di...8, third quarter results were reduced by a $0.03 p...
(Date:11/4/2009)...E, N.Y., Oct. 21 What,s the cost o...ng accidental death resulting from prescription me... good intentions, however, may be unaware that the...heir teens from the ticking timebomb of prescripti... in premium-quality medical supplies, has formed a...
(Date:11/4/2009)...YORK, Oct. 27 Global Rainmakers, I...advanced R&D laboratory, today announced that ...repared to actively commercialize its suite of tec...ric security offerings. ,, During the past four...dollars to develop and deploy a series of core--bu...
Breaking Biology News(10 mins):Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi aventis in the U S 13374 1The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi aventis in the U S 13374 2The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi aventis in the U S 13374 3The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi aventis in the U S 13374 4NewCardio Announces Master Services Agreement With Dedicated Phase I 4828 1NewCardio Announces Master Services Agreement With Dedicated Phase I 4828 2NewCardio Announces Master Services Agreement With Dedicated Phase I 4828 3NewCardio Announces Master Services Agreement With Dedicated Phase I 4828 4ReGen Biologics Clarifies Recent Press about the Menaflex Device 53699 1ReGen Biologics Clarifies Recent Press about the Menaflex Device 53699 2
...pths of the South Pacific Ocean harbor toxins that..., according to research findings from University o...colleagues. , The research team has defined the st...anding that can be used to synthesize pharmaceutic...he Proceedings of the National Academy of Sciences...
...at was found be an ozone depletor are now being ev...a, say plant pathologists with USDA,s Agricultural...ontreal Protocol called for the phase-out of methy...ne fungi, nematodes, and weeds of more than 100 cr...romide,s ability to deplete ozone and disrupt the ...
...ase, destroying invading microbes with a swarm of ... apparent reason, ganging up on normal tissues in ...ple each year, the immune system attacks the inner...llow us to hear. Without warning, in days or weeks... ears. Some might get part or all of their hearing...
Other Biology News:Structures of marine toxins provide insight into their effectiveness as cancer drugs 2Plant pathologists evaluate eco-friendly alternatives to methyl bromide 2New Lab Research May Help Those Deafened By Immune System Attack 2New Lab Research May Help Those Deafened By Immune System Attack 3New Lab Research May Help Those Deafened By Immune System Attack 4
... Mixes are formulated for use in one-step QRT-PCR ...en. One-step QRT-PCR mixes offer a quick and simpl...e minimised, making the protocol easy to follow an...x is supplied with a patented blend of RTases comb...
SphingoBeads from Echelon Biosciences Inc.
...thetic Peptide: M(1) E F L P E P Q H P P G P P T M...tein 3 (Mint3) from mouse cells.,PA1-072 has ... By Western blot, this antibody detects an ~86 kD...ct.,PA1-072 immunizing peptide corresponds to...
Rabbit Anti-Staphylococcus Enterotoxin A Polyclonal Antibody, Horseradish Peroxidase Conjugated from Abcam
Biology Products: